EMA Authorised: Ertapenem SUN (ertapenem sodium) — SUN Pharmaceutical Industries (Europe) B.V.

View source ↗

Summary

The EMA authorised Ertapenem SUN (ertapenem sodium) by SUN Pharmaceutical Industries (Europe) B.V. for bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Ertapenem SUN (ertapenem)

Snippet

Status: Authorised. Therapeutic area: Bacterial Infections. MAH: SUN Pharmaceutical Industries (Europe) B.V.. Decision date: 02/04/2024